Vipin Yadav

Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers

Sheng-Bin Peng, James R. Henry, Michael D. Kaufman et al. · Cancer Cell · 2015 · 309 citations · Full text

Medicine, Cancer Biology, Oncology +16

Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma

Vipin Yadav, Xiaoyi Zhang, Jiangang Liu et al. · Journal of Biological Chemistry · 2012 · 204 citations · Full text

Medicine, Oncology, Pharmacology +15

Oncogenic <i>BRAF</i> Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120

Shih-Hsun Chen, Youyan Zhang, Robert D. Van Horn et al. · Cancer Discovery · 2016 · 172 citations

Life Sciences, Molecular Biology, Oncology +15

Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets

Ying Chen, Jeremy McGee, Xian‐Ming Chen et al. · PLoS ONE · 2014 · 136 citations · Full text

Life Sciences, Genetics, Oncology +17

The CDK4/6 Inhibitor LY2835219 Overcomes Vemurafenib Resistance Resulting from MAPK Reactivation and Cyclin D1 Upregulation

Vipin Yadav, Teresa F. Burke, Lysiane Huber et al. · Molecular Cancer Therapeutics · 2014 · 135 citations

Medicine, Oncology, Pharmacology +16